Currently out of the existing stock ratings of Shibani Malhotra, 12 are a BUY (80%), 3 are a HOLD (20%).

Shibani Malhotra

Work Performance Price Targets & Ratings Chart

Analyst Shibani Malhotra, carries an average stock price target met ratio of 56.67% that have a potential upside of 13.78% achieved within 324 days. Previously, Shibani Malhotra worked at NOMURA.

Shibani Malhotra’s has documented 28 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AKRX, Akorn at 23-Mar-2016.

Wall Street Analyst Shibani Malhotra

Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for ENDP (ENDO INTERNATIONAL PLC) at 5/1/2014. The price target of $66 was fulfilled within 1 day with a profit of $0.36 (0.54%) receiving and performance score of 5.42.

Average potential price target upside

AGN Allergan plc ENDP Endo International PLC AKRX Akorn TEVA Teva Pharma Industries Ltd ADR

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 21-Apr-2020

$193

$-0.02 (-0.01%)

$178

5 years 8 months 18 days ago
(21-Apr-2020)

2/8 (25%)

$8.96 (4.87%)

125

Buy

$203

5 years 10 months 22 days ago
(18-Feb-2020)

1/2 (50%)

$20.22 (11.61%)

95

Hold

Since 30-Jan-2019

$203

$9.98 (5.17%)

$178

5 years 10 months 29 days ago
(10-Feb-2020)

5/16 (31.25%)

$4.87 (2.46%)

74

Hold

Since 22-Jan-2020

$188

5 years 11 months 17 days ago
(22-Jan-2020)

2/11 (18.18%)

$50.95 (37.18%)

254

Hold

Since 19-Nov-2019

$200

6 years 1 months 20 days ago
(19-Nov-2019)

2/11 (18.18%)

$73.92 (58.63%)

290

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Shibani Malhotra?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?